Clinical trial
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00409773 |
|---|---|
| Title | Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Parallel Arm, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin Versus Atorvastatin in Patients With Metabolic Syndrome and Hypercholesterolemia at High Risk for Coronary Heart Disease |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | ezetimibe (+) simvastatin, Comparator: atorvastatin calcium, Comparator: Placebo (unspecified) |
| Enrollment | 1,143 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Dec 11, 2006 |
| Last update posted | May 16, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: